What is currently the recommended hemostatic agent for controlling bleeding during vital pulp therapy (e.g., pulpotomy)?

Per AAE and AAPD guidance and current literature, sodium hypochlorite (typically 2-5%) applied to the pulp wound is the modern evidence-based hemostatic agent of choice in vital pulp therapy — it achieves hemostasis, disinfects the wound, dissolves the blood clot/fibrin, and removes debris simultaneously. Calcium hydroxide is the classic capping material placed AFTER hemostasis has been achieved, not the agent used to achieve hemostasis itself.